Evidence map›Paper›PMID 31409289›Full record

ArticleBMC infectious diseases2019

Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.

Ameet Dravid, Kartik Natarajan, Mahenderkumar Medisetty, Raviraj Gawali, Uma Mahajan, Milind Kulkarni, Chinmay Saraf, Charuta Ghanekar, Sachin Kore, Niranjan Rathod and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ameet DravidDepartment of Medicine, Ruby Hall Clinic, Pune, Maharashtra, India. ameet.dravid@gmail.com.ORCID http://orcid.org/0000-0002-1909-7530
Kartik NatarajanDepartment of Medicine, Poona Hospital and Research Centre, Pune, Maharashtra, India.
Mahenderkumar MedisettyDepartment of Medicine, Poona Hospital and Research Centre, Pune, Maharashtra, India.
Raviraj GawaliDepartment of Medicine, Poona Hospital and Research Centre, Pune, Maharashtra, India.
Uma MahajanDepartment of Biostatistics, Precision Diagnostics and Biosciences, Pune, Maharashtra, India.
Milind KulkarniDepartment of Medicine, Ruby Hall Clinic, Pune, Maharashtra, India.
Chinmay SarafDepartment of Pathology, Precision Diagnostics and Biosciences, Pune, Maharashtra, India.
Charuta GhanekarDepartment of Microbiology, Poona Hospital and Research Centre, Pune, Maharashtra, India.
Sachin KoreDepartment of Dermatology, Ashwini Sahakari Rugnalaya and Research Centre, Solapur, Maharashtra, India.
Niranjan RathodDepartment of Medicine, Apex hospital, Kolhapur, Maharashtra, India.
Mrudula DravidDepartment of Microbiology, Infectious Disease Clinic, Dhule, Maharashtra, India.
Hi Tech BioSciences India (India) · INRuby Hall Clinic · INApex Heart Institute · INAshwini Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite rapid scale up of antiretroviral therapy (ART), Tuberculosis (TB) remains the commonest opportunistic infection and cause of death among HIV infected individuals in resource limited settings like India. Incidence of TB in individuals on ART in private healthcare sector in India is infrequently studied.

methodsThis retrospective cohort study conducted between 1st March 2009 and 1st March 2017 aimed to evaluate rate of incident TB in individuals initiated on ART at 3 private sector ART clinics in Pune, India. Individuals more than 12 years of age with ART duration of atleast 6 months were included. Patients were classified as having prevalent TB if they had a TB episode within the year prior to ART initiation or if they developed TB within 6 months of starting ART. Individuals who were diagnosed with TB after 6 months of starting ART were classified as incident TB cases. A recurrent episode of TB after treatment completion or cure of prevalent TB was also regarded as incident TB. Patients were classified as definitive TB if Mycobacterium tuberculosis was grown in culture from a biological sample or a positive rapid molecular test. Patients were classified as probable TB if there was radiologic evidence of TB in absence of confirmatory culture or PCR.

results1904 patients with a median duration of follow up on ART of 57 (IQR = 32.0, 84.0) months were included. Of these, 182 developed incident TB (22% definitive TB, 38% recurrent cases). TB incidence at 6-12 months, 13-24 months, 25-60 months and > 60 months of ART was 24.32, 5.46, 2.54 and 0.75 cases per 100 person years respectively. Current time updated CD4 count < 500 cells/mm

conclusionStarting ART early in treatment naïve individuals, prompt detection of virologic failure on ART and providing IPT along with ART will be useful in reducing incident TB. Efforts from private sector are crucial in achieving Sustainable Development Goals set by Government of India and attaining the vision of a TB free India.

Indexed as

AdultAIDS-Related Opportunistic InfectionsAnti-HIV AgentsCD4 Lymphocyte CountCohort StudiesFemaleHealth Care SectorHIV InfectionsHumansIncidenceIndiaMaleMiddle AgedPrivate SectorProportional Hazards ModelsRetrospective StudiesAnti-HIV AgentsAntiretroviral therapyHIVIncident tuberculosisIndiaIsoniazid preventive therapyPrivate healthcare sector

Identifiers

PMID31409289
PMCPMC6692924
OpenAlexW2968071515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.